| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 332 |
| 1 | OCRELIZUMAB | 268 |
| 2 | PREDNISONE | 266 |
| 3 | METHOTREXATE SODIUM | 228 |
| 4 | METHOTREXATE | 192 |
| 5 | CLOZAPINE | 186 |
| 6 | TACROLIMUS | 185 |
| 7 | NIRAPARIB | 183 |
| 8 | IBUPROFEN | 170 |
| 9 | NALTREXONE | 163 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRANKINCENSE | 2 | 0.0328 |
| 1 | COUMARIN | 3 | 0.0183 |
| 2 | DAPRODUSTAT | 19 | 0.0095 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 71 | 0.0083 |
| 4 | NIRAPARIB | 183 | 0.0083 |
| 5 | VOXELOTOR | 152 | 0.0068 |
| 6 | SOYBEAN OIL | 4 | 0.0059 |
| 7 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 2 | 0.0058 |
| 8 | NALTREXONE | 163 | 0.0053 |
| 9 | ONASEMNOGENE ABEPARVOVEC-XIOI | 12 | 0.0052 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 666 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 457 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 455 |
| 3 | Thalidomide Analog [EPC] | 434 |
| 4 | Atypical Antipsychotic [EPC] | 242 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 192 |
| 6 | Kinase Inhibitor [EPC] | 178 |
| 7 | Benzodiazepine [EPC] | 167 |
| 8 | Proton Pump Inhibitor [EPC] | 165 |
| 9 | Vitamin C [EPC] | 159 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 19 | 0.0084 |
| 1 | Hemoglobin S Polymerization Inhibitor [EPC] | 152 | 0.0068 |
| 2 | Glinide [EPC] | 31 | 0.0035 |
| 3 | Benzodiazepine Antagonist [EPC] | 3 | 0.0034 |
| 4 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 11 | 0.0033 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 6 | Asparagine-specific Enzyme [EPC] | 36 | 0.0027 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 83 | 0.0026 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 9 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |